Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.

Vpr (Viral protein-R) of the Human Immunodeficiency Virus type-1 is a 14-kDa virion-associated protein, conserved in HIV-1, -2 and the Simian Immunodeficiency Virus (SIV). Vpr is incorporated into the virion, travels to the nucleus, and has multiple activities including promoter activation, cell cycle arrest at the G2/M transition and apoptosis induction. Through these activities, Vpr is thought to influence not only viral replication but also numerous host cell functions. These functions may be categorized in three groups depending on the domains of Vpr that support them: (1) functions mediated by the amino terminal portion of Vpr, like virion packaging; (2) functions mediated by the carboxyl terminal portion such as cell cycle arrest; and (3) functions that depend on central alpha-helical structures such as transcriptional activation, apoptosis and subcellular shuttling. Association of these activities to specific regions of the Vpr molecule appears to correlate to the host/viral molecules that interact with corresponding portion of Vpr. They include Gag, host transcription factors/coactivators such as SP1, the glucocorticoid receptor, p300/CREB-binding protein and TFIIB, apoptotic adenine nucleotide translocator, cyclophilin A and 14-3-3 proteins. The properties of Vpr molecule has made it difficult to assess its function and determine the true cellular interactors. Further studies on Vpr function are needed to fully assess the function of this important early regulatory molecule of HIV and other lentiviruses.

[1]  M. Kamata,et al.  A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. , 2005, Microbes and infection.

[2]  G. Chrousos,et al.  Vpr Protein of Human Immunodeficiency Virus Type 1 Binds to 14-3-3 Proteins and Facilitates Complex Formation with Cdc25C: Implications for Cell Cycle Arrest , 2005, Journal of Virology.

[3]  Y. Wang,et al.  Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  M. Lairmore,et al.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth , 2005, Cell Death and Differentiation.

[5]  U. Schubert,et al.  Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells , 2000, Journal of Virology.

[6]  D. Green,et al.  HIV-1 Vpr Induces Apoptosis through Caspase 9 in T Cells and Peripheral Blood Mononuclear Cells* , 2002, The Journal of Biological Chemistry.

[7]  D. Weiner,et al.  HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D O Morgan,et al.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity , 1995, Journal of virology.

[9]  H. Okayama,et al.  Genetic Studies with the Fission YeastSchizosaccharomyces pombe Suggest Involvement of Wee1, Ppa2, and Rad24 in Induction of Cell Cycle Arrest by Human Immunodeficiency Virus Type 1 Vpr , 2000, Journal of Virology.

[10]  N. Jullian,et al.  Structure, biological functions and inhibition of the HIV-1 proteins Vpr and NCp7. , 1997, Biochimie.

[11]  G. Chrousos,et al.  AIDS-related insulin resistance and lipodystrophy syndrome. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[12]  Philippe P Roux,et al.  Activation of Transcription Factors NF-κB and NF-IL-6 by Human Immunodeficiency Virus Type 1 Protein R (Vpr) Induces Interleukin-8 Expression , 2000, Journal of Virology.

[13]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[14]  F. Boisvert,et al.  Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation , 1995, Journal of virology.

[15]  M. Emerman HIV-1, Vpr and the cell cycle , 1996, Current Biology.

[16]  É. Cohen,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection , 1999, Journal of Virology.

[17]  P. Gage,et al.  Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Kinzler,et al.  14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.

[19]  O. Narayan,et al.  Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat (*) , 1995, The Journal of Biological Chemistry.

[20]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[21]  W. Greene,et al.  Nucleocytoplasmic Shuttling by Human Immunodeficiency Virus Type 1 Vpr , 2001, Journal of Virology.

[22]  Anthony J. Muslin,et al.  14-3-3 proteins: regulation of subcellular localization by molecular interference. , 2000, Cellular signalling.

[23]  W. Paxton,et al.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.

[24]  J. Luban,et al.  Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B , 1995, Journal of virology.

[25]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[26]  É. Cohen,et al.  The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells , 1998, Journal of Virology.

[27]  K L Gould,et al.  Regulating the onset of mitosis. , 1999, Current opinion in cell biology.

[28]  O. Narayan,et al.  Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. , 1994, The Journal of biological chemistry.

[29]  O. Narayan,et al.  Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. , 1994, The Journal of biological chemistry.

[30]  P. Russell,et al.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein , 1999, Nature.

[31]  R. Zhao,et al.  Viral infections and cell cycle G2/M regulation , 2005, Cell Research.

[32]  I. Chen,et al.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest , 1997, Journal of virology.

[33]  L. Ratner,et al.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions , 1993, Journal of virology.

[34]  J. Fernández,et al.  A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. , 1999, Genes & development.

[35]  Guido Kroemer,et al.  Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2 , 2001, The Journal of experimental medicine.

[36]  D. Green,et al.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB , 1997, Nature Medicine.

[37]  G. Kroemer,et al.  The HIV-1 Viral Protein R Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore , 2000, The Journal of experimental medicine.

[38]  R. Gorelick,et al.  A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles , 1995, Journal of virology.

[39]  Meng Chen,et al.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle , 1995, Journal of virology.

[40]  M. Chen,et al.  Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. , 2000, Virus research.

[41]  A. Kumagai,et al.  Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. , 2001, Molecular biology of the cell.

[42]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[43]  B. Roques,et al.  Direct activation of protein phosphatase‐2A0 by HIV‐1 encoded protein complex NCp7:vpr , 1997, FEBS letters.

[44]  Mong-Hong Lee,et al.  Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression* , 2000, The Journal of Biological Chemistry.

[45]  G. Blobel,et al.  Viral protein R regulates nuclear import of the HIV‐1 pre‐integration complex , 1998, The EMBO journal.

[46]  D. Weiner,et al.  Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Göttlinger,et al.  A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr , 1996, Journal of virology.

[48]  S. Mahalingam,et al.  Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. , 1995, Virology.

[49]  G. Blobel,et al.  Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex* , 1998, The Journal of Biological Chemistry.

[50]  F. Hanaoka,et al.  Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair , 1997, Journal of virology.

[51]  P. Gage,et al.  The Amino-Terminal Region of Vpr from Human Immunodeficiency Virus Type 1 Forms Ion Channels and Kills Neurons , 1999, Journal of Virology.

[52]  C. Depienne,et al.  Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. , 2001, Virology.

[53]  J. Sodroski,et al.  Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.

[54]  S. Wain-Hobson,et al.  The molecular biology of HIV-1. , 1994 .

[55]  G. Chrousos,et al.  HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. , 1998, Virology.

[56]  P. Henklein,et al.  Structural Characterization of the HIV-1 Vpr N Terminus , 2003, Journal of Biological Chemistry.

[57]  K. Khalili,et al.  Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.

[58]  Robert J. Ferl,et al.  Evolution of the 14-3-3 Protein Family: Does the Large Number of Isoforms in Multicellular Organisms Reflect Functional Specificity? , 2000, Journal of Molecular Evolution.

[59]  J. Feigon,et al.  Biochemical and structural analysis of the interaction between the UBA(2) domain of the DNA repair protein HHR23A and HIV-1 Vpr. , 2000, Biochemistry.

[60]  M. Kamata,et al.  A Carboxy-Terminally Truncated Form of the Human Immunodeficiency Virus Type 1 Vpr Protein Induces Apoptosis via G1 Cell Cycle Arrest , 2000, Journal of Virology.

[61]  B. Roques,et al.  The Zinc Fingers of HIV Nucleocapsid Protein NCp7 Direct Interactions with the Viral Regulatory Protein Vpr* , 1997, The Journal of Biological Chemistry.

[62]  D. Weiner,et al.  The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[63]  I. Chen,et al.  Depletion of Wee-1 Kinase Is Necessary for both Human Immunodeficiency Virus Type 1 Vpr- and Gamma Irradiation-Induced Apoptosis , 2003, Journal of Virology.

[64]  M. Morris,et al.  An Essential Phosphorylation-site Domain of Human cdc25C Interacts with Both 14-3-3 and Cyclins* , 2000, The Journal of Biological Chemistry.

[65]  B. Roques,et al.  NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr. , 1999, European journal of biochemistry.

[66]  Wesley I. Sundquist,et al.  Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag , 2001, Journal of Virology.

[67]  M. Ramanathan,et al.  Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling* , 2002, The Journal of Biological Chemistry.

[68]  R. Pomerantz,et al.  Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis in Human Neuronal Cells , 2000, Journal of Virology.

[69]  G. Chrousos,et al.  Protein 14-3-3σ Interacts with and Favors Cytoplasmic Subcellular Localization of the Glucocorticoid Receptor, Acting as a Negative Regulator of the Glucocorticoid Signaling Pathway* , 2003, Journal of Biological Chemistry.

[70]  É. Cohen,et al.  Role of auxiliary proteins in retroviral morphogenesis. , 1996, Current topics in microbiology and immunology.

[71]  S. Moreno,et al.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.

[72]  L. M. Mansky,et al.  The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate , 2000, Journal of Virology.

[73]  M. Emerman,et al.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[74]  The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. , 1996, Biochemical and biophysical research communications.

[75]  A. Nebreda,et al.  Regulation of the meiotic cell cycle in oocytes. , 2000, Current opinion in cell biology.

[76]  J. Decaprio,et al.  Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site , 1999, Molecular and Cellular Biology.

[77]  Jeremy Luban,et al.  Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression* , 2003, Journal of Biological Chemistry.

[78]  N. Walworth,et al.  Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage. , 1999, Genes & development.

[79]  F. Rey,et al.  The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. , 1996, Journal of molecular biology.

[80]  J. Sodroski,et al.  Identification of HIV-1 vpr product and function. , 1990, Journal of acquired immune deficiency syndromes.

[81]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[82]  P. Silver,et al.  HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. , 1998, Genes & development.

[83]  Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. , 1996, Virology.

[84]  J. Feigon,et al.  Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr , 1998, Nature Structural Biology.

[85]  F. Mammano,et al.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles , 1995, Journal of virology.

[86]  D. Weiner,et al.  Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr , 1997, Journal of virology.

[87]  J. Kim,et al.  The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. , 2002, DNA and cell biology.

[88]  É. Cohen,et al.  Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor* , 1999, The Journal of Biological Chemistry.

[89]  Ling-jun Zhao,et al.  Pro-apoptotic Activity of HIV-1 Auxiliary Regulatory Protein Vpr Is Subtype-dependent and Potently Enhanced by Nonconservative Changes of the Leucine Residue at Position 64* , 2003, Journal of Biological Chemistry.

[90]  R. Knoblauch,et al.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr , 1995, Journal of virology.

[91]  F. Rey,et al.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme , 1996, Journal of virology.

[92]  L. Zhao,et al.  Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. , 1998, Gene.

[93]  R. Murali,et al.  Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[94]  G. Chrousos,et al.  The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor , 1999 .

[95]  I. Chen,et al.  Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation , 2000, Journal of Virology.

[96]  I. Chen,et al.  Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[97]  O. J. Semmes,et al.  Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response , 2005, Oncogene.

[98]  M. Yanagida,et al.  HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. , 2001, Virology.

[99]  M. Yaffe,et al.  The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[100]  M. A. Vodicka,et al.  Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest , 1997, Journal of virology.

[101]  M. Yaffe,et al.  Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. , 1999, Molecular cell.

[102]  B. Roques,et al.  NMR structure of the HIV-1 regulatory protein VPR. , 2003, Journal of molecular biology.

[103]  L. Stark,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Viral Protein R (Vpr) Interacts with Lys-tRNA Synthetase: Implications for Priming of HIV-1 Reverse Transcription , 1998, Journal of Virology.

[104]  M. Emerman,et al.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection , 1995, Journal of virology.

[105]  M. Nowak,et al.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo , 1998, Nature Medicine.

[106]  R. Pomerantz,et al.  Diversity of HIV-1 Vpr Interactions Involves Usage of the WXXF Motif of Host Cell Proteins* , 1998, The Journal of Biological Chemistry.

[107]  S. Mahalingam,et al.  The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. , 1995, Virology.

[108]  M. Bukrinsky,et al.  Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. , 2000, Journal of molecular biology.

[109]  N. McKenna,et al.  Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functionsProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[110]  Xiaojian Yao,et al.  Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. , 1998, Journal of molecular biology.

[111]  C. Peng,et al.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.

[112]  R. Desrosiers,et al.  Copyright � 1995, American Society for Microbiology Progression to AIDS in the Absence of a Gene for vpr or vpx , 1994 .

[113]  G. Chrousos,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Accessory Protein Vpr Induces Transcription of the HIV-1 and Glucocorticoid-Responsive Promoters by Binding Directly to p300/CBP Coactivators , 2002, Journal of Virology.

[114]  P. Graves,et al.  Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding , 2001, Oncogene.

[115]  B. Roques,et al.  NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. , 1999, Journal of molecular biology.

[116]  J. Pines,et al.  Cyclins and the G2/M transition. , 1997, Cancer surveys.